Abstract
Increased awareness and wider availability of guidance to treat familial hypercholesterolaemia will improve management of familial hypercholesterolaemia. New therapies, if they become available after appropriate outcome studies, will reduce LDL-C levels in both homozygous familial hypercholesterolaemia and severe heterozygous familial hypercholesterolaemia, thus reducing the risk for premature CHD.
Original language | English |
---|---|
Pages (from-to) | 381-388 |
Number of pages | 8 |
Journal | Current Opinion in Cardiology |
Volume | 29 |
Issue number | 4 |
DOIs | |
Publication status | Published - Jul 2014 |
Keywords
- Familial hypercholesterolaemia
- Guidelines for familial hypercholesterolaemia
- Premature coronary heart disease
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine